hi goldmad...i tend to agree with you on your guess and I am more confident now that maybe they are looking at it really closely to assure its progression into p3. i think they would most likely have made a decision by now if we were not in the running for p3.
FDA delay for ph 3 trial approval, page-22
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $78.73M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 23.0¢ | 21.5¢ | $78.13K | 350.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 64880 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 43479 | 1 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |